Tiedemann Trust’s Celgene Corp CELG Stock Holding History

Tiedemann Trust’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-16,000	Closed	-$935K	–	116
2013 Q2	$935K	Buy	+16,000	New	+$963K	0.16%	47

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Tiedemann Trust's CELG Position: Q3 2013 in Review

Tiedemann Trust sold out of Celgene Corp (CELG) in Q3 2013, closing a stake of 16,000 shares — an estimated $935K sold.

Tiedemann Trust first reported a position in CELG in Q2 2013 and held it in 1 quarter. The position peaked at $935K in Q2 2013. 909 funds tracked by Wall St. Rank hold CELG as of Q3 2013.

Tiedemann Trust reported no remaining Celgene Corp position as of Q3 2013 after selling out during the quarter.
Tiedemann Trust sold 16,000 Celgene Corp shares in Q3 2013, an estimated $935K.
Tiedemann Trust first reported a position in Celgene Corp in Q2 2013 and held it in 1 quarter.
Tiedemann Trust's Celgene Corp position peaked at $935K in Q2 2013.
909 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2013.

Based on Tiedemann Trust's 13F filing for Q3 2013, filed 12 Nov 2013.